http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4810700-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b49b135f099e96a0e4cab2427a48ae8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate | 1983-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1989-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1761fec45b97fde194baeaa7db4d8e65 |
| publicationDate | 1989-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4810700-A |
| titleOfInvention | Compositions inhibiting estrogen sulfotransferase activity |
| abstract | An estrogen sulfotransferase inhibitor composition comprises a compound of the formula ##STR1## wherein R 1 is F, Br, NO 2 , or H; R 2 is F, Br, NO 2 , NH 2 , or H; R is H or alkyl of 1-4 carbon atoms; R 3 is O or H 2 ; and R 4 is H 2 , O, or α-H, β-OH; R 5 is H 2 , α-H and β-OH or B-H and α-OH in admixture with a pharmaceutically acceptable carrier with the proviso that R 1 , R 2 and R 3 cannot all be hydrogen and one of R 1 and R 2 is F. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010048638-A1 |
| priorityDate | 1978-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.